Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIFEPRISTONE vs MILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIFEPRISTONE vs MILNACIPRAN: Safety Overview

Metric MIFEPRISTONE MILNACIPRAN
Total FAERS Reports 4,492 1,392
Deaths Reported 294 120
Death Rate 6.5% 8.6%
Hospitalizations 1,322 274
Average Patient Age 46.2 yrs 54.8 yrs
% Female Patients 84.4% 82.6%
FDA Approval Date Apr 11, 2019 Apr 22, 2016
Manufacturer Corcept Therapeutics Incorporated Cardinal Health 107, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription